Does AVAPRITINIB Cause Salivary hypersecretion? 43 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Salivary hypersecretion have been filed in association with AVAPRITINIB (Ayvakit). This represents 0.4% of all adverse event reports for AVAPRITINIB.
43
Reports of Salivary hypersecretion with AVAPRITINIB
0.4%
of all AVAPRITINIB reports
3
Deaths
15
Hospitalizations
How Dangerous Is Salivary hypersecretion From AVAPRITINIB?
Of the 43 reports, 3 (7.0%) resulted in death, 15 (34.9%) required hospitalization.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AVAPRITINIB. However, 43 reports have been filed with the FAERS database.
What Other Side Effects Does AVAPRITINIB Cause?
Fatigue (1,527)
Off label use (1,138)
Nausea (1,033)
Diarrhoea (886)
Swelling face (481)
Memory impairment (467)
Dizziness (458)
Vomiting (456)
Headache (454)
Asthenia (433)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which AVAPRITINIB Alternatives Have Lower Salivary hypersecretion Risk?
AVAPRITINIB vs AVASTIN
AVAPRITINIB vs AVATROMBOPAG
AVAPRITINIB vs AVELOX
AVAPRITINIB vs AVELUMAB
AVAPRITINIB vs AVIBACTAM